Stem Cell Research & Therapy
Scope & Guideline
Unlocking the Potential of Stem Cells for Tomorrow
Introduction
Aims and Scopes
- Stem Cell Characterization and Mechanisms:
Research articles often explore the biological characteristics, differentiation potential, and mechanisms of action of various types of stem cells, including mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and other progenitor cells. - Therapeutic Applications of Stem Cells:
The journal publishes studies on the clinical applications of stem cells in treating a variety of diseases and conditions, such as autoimmune disorders, cardiovascular diseases, and neurological conditions, emphasizing their potential in regenerative medicine. - Extracellular Vesicles and Secretome:
A significant focus is placed on the role of stem cell-derived extracellular vesicles and secretomes, highlighting their therapeutic potential in modulating immune responses, enhancing tissue repair, and their applications in drug delivery. - Innovative Techniques in Stem Cell Research:
The journal features advancements in methodologies for stem cell isolation, culture, and differentiation, including bioprinting, 3D culture systems, and genetic engineering techniques like CRISPR/Cas9. - Interdisciplinary Approaches in Stem Cell Therapy:
Research often integrates approaches from molecular biology, immunology, and bioengineering to address challenges in stem cell therapy, including issues related to cell survival, engraftment, and immune modulation.
Trending and Emerging
- Regenerative Medicine and Tissue Engineering:
There is a growing emphasis on the use of stem cells in regenerative medicine and tissue engineering, with numerous studies focusing on their ability to repair and regenerate damaged tissues and organs, particularly in orthopedic and cardiovascular applications. - Stem Cell-Derived Exosomes and Their Therapeutics:
Research on exosomes derived from stem cells is rapidly increasing, highlighting their potential as a cell-free therapeutic strategy for various diseases, including cancer, cardiovascular diseases, and neurodegenerative conditions. - Immunomodulatory Properties of Stem Cells:
The immunomodulatory effects of stem cells, especially in the context of inflammatory diseases and transplant rejection, are gaining attention, as studies explore how stem cells can modulate immune responses to enhance therapeutic outcomes. - Personalized Stem Cell Therapies:
There is a trend towards personalized approaches in stem cell therapies, including the use of patient-derived iPSCs to create tailored treatments for individual patients, particularly in genetic disorders and cancer. - Stem Cell Therapy for COVID-19 and Other Acute Conditions:
The journal has seen an increase in research focusing on the application of stem cell therapies in treating COVID-19 and other acute conditions, exploring their potential in immune modulation and tissue repair.
Declining or Waning
- Traditional Stem Cell Sources:
There has been a noticeable decrease in studies focusing on traditional sources of stem cells, such as bone marrow and embryonic stem cells, as research increasingly shifts towards more versatile and ethically favorable sources, such as iPSCs and MSCs from various tissues. - Basic Stem Cell Biology:
Research that solely focuses on basic stem cell biology without direct clinical applications appears to be declining. The trend is moving towards more translational studies that emphasize therapeutic implications and clinical outcomes. - End-of-Life Applications of Stem Cells:
The exploration of stem cell therapies for end-of-life conditions has decreased, as the journal emphasizes more on regenerative applications and therapeutic interventions that can significantly improve patient outcomes.
Similar Journals
DIFFERENTIATION
Advancing the Frontiers of Cellular UnderstandingDIFFERENTIATION is a respected peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing knowledge in the fields of Cancer Research, Cell Biology, Developmental Biology, and Molecular Biology. With an established history since 1973, the journal continuously explores the intricacies of cellular and molecular processes that govern differentiation in biological systems, thus playing a pivotal role in shaping contemporary research directions. Currently indexed in the Q3 quartile across multiple relevant categories, it provides a crucial platform for researchers to disseminate their findings and engage with the scientific community. DIFFERENTIATION does not offer open access, but it remains a valuable resource for academics seeking to enhance their understanding of the fundamental mechanisms that underpin life sciences. By fostering a rigorous dialogue among scientists, it contributes significantly to the ever-evolving landscape of biochemistry and genetics.
Regenerative Engineering and Translational Medicine
Driving Innovation at the Intersection of Science and HealthRegenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.
American Journal of Stem Cells
Advancing regenerative medicine through groundbreaking research.American Journal of Stem Cells is a leading multidisciplinary publication dedicated to advancing the field of regenerative medicine and stem cell research. Published by E-CENTURY PUBLISHING CORP, this journal has gained recognition for its commitment to high-quality scientific contributions, achieving impressive rankings within the Scopus database, particularly in the areas of Biochemistry, Genetics and Molecular Biology, and Developmental Biology. With its focus on innovative research, the journal offers crucial insights and developments that appeal to researchers, professionals, and students alike. Although it is not an open-access journal, the American Journal of Stem Cells plays a pivotal role in disseminating impactful findings that define the future of cellular therapies and regenerative methodologies. The journal's past coverage from 2012 to 2017 reflects its dedication to advancing knowledge in key scientific disciplines, making it an essential resource for anyone engaged in the dynamic landscape of stem cell science.
Cells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.
Current Stem Cell Research & Therapy
Connecting Global Researchers in Stem Cell TherapyCurrent Stem Cell Research & Therapy, published by Bentham Science Publishers Ltd, is a leading journal dedicated to advancing the field of stem cell research. With an ISSN of 1574-888X and an E-ISSN of 2212-3946, this journal has been a valuable resource since its inception in 2006 and continues to broaden its scope through 2024. Recognized in the Q2 quartile for Medicine (miscellaneous) and ranked in the 66th percentile among its peers, the journal plays a crucial role in disseminating high-quality, peer-reviewed research that explores both the therapeutic and biological implications of stem cells. Located in the United Arab Emirates, Current Stem Cell Research & Therapy embraces a global audience of researchers, professionals, and students, providing a vibrant platform for discourse and innovation. While the journal offers subscription-based access, it remains committed to enhancing the scientific community's understanding of stem cell therapy and its applications across various medical fields.
Tissue Engineering and Regenerative Medicine
Innovative Insights for the Future of Regenerative MedicineTissue Engineering and Regenerative Medicine, published by the Korean Tissue Engineering Regenerative Medicine Society, is a distinguished journal focusing on the interdisciplinary fields of tissue engineering, regenerative medicine, and related biomedical innovations. With an ISSN of 1738-2696 and an E-ISSN of 2212-5469, this journal disseminates cutting-edge research and advancements pivotal to developing therapeutic strategies that improve tissue function and repair. As a testament to its scholarly impact, it holds a Q2 ranking in both Biomedical Engineering and Medicine (miscellaneous) categories, reflecting its influence and relevance within the scientific community, particularly with a Scopus rank placing it in the 82nd percentile among similar journals. Although the journal does not offer open access, it provides vital insights and knowledge to researchers, professionals, and students involved in the quest for innovative solutions in medical science and engineering. With its convergence years extending from 2008 to 2024, the journal continues to be an essential platform for the dissemination of high-quality research that drives the field forward.
Stem Cell Research
Bridging discovery and clinical innovation.Stem Cell Research is a premier Open Access journal published by ELSEVIER, dedicated to advancing the understanding of stem cell biology. Since its inception in 2007, the journal has provided a platform for the latest research in the fields of Cell Biology, Developmental Biology, and Medicine, with its publication being accessible globally since 2014. Located in the Netherlands, the journal’s comprehensive scope aims to bridge fundamental discoveries with clinical applications, fostering collaboration among researchers and professionals. With a 2023 impact factor reflected in its Q4 ranking in Cell and Developmental Biology and a commendable position in the 64th percentile for General Medicine, Stem Cell Research remains a vital resource for those interested in the dynamic landscape of regenerative medicine. Targeting an audience that includes researchers, practitioners, and students, the journal emphasizes not only the significance of stem cells in medical science but also the ethical considerations and the public discourse surrounding stem cell research. Join the community committed to pioneering the future of stem cell science through rigorous peer-reviewed research.
Stem Cells International
Fostering Collaboration in Cutting-edge Stem Cell ResearchStem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.
BIOCELL
Pioneering Discoveries in Molecular BiologyBIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.
CELL PROLIFERATION
Bridging Knowledge Gaps in Cell Proliferation StudiesCELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.